SOLVING ACTIVE INGREDIENT HOMOGENEITY PROBLEM OF BENZYDAMINE HCL LOZENGES WITH MIXING METHOD MODIFICATION
Mixing process variation of the drugs active ingredients in the granulation phase is one of the important factors in the homogeneity of drugs that contain a small amount of active ingredient, such as Benzydamine HCl tablets. Increase of method sensitivity due to analysis method update for Benzyda...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/56537 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Mixing process variation of the drugs active ingredients in the granulation phase
is one of the important factors in the homogeneity of drugs that contain a small
amount of active ingredient, such as Benzydamine HCl tablets. Increase of
method sensitivity due to analysis method update for Benzydamine HCl tablet
assay from spectrophotometry to HPLC, makes the inhomogeneity issue in the
parameters of content uniformity become apparent. The aim of this study was to
solve the homogeneity problem of Benzydamine HCl and its primary outcome was
to obtain the content uniformity of Benzydamine HCl within the range 85 - 115%
for its individual data and the acceptance value (AV) ?15%. The solution
approach to the homogeneity problem of Benzydamine HCl tablets was carried
out using the 8-steps Plan, Do, Check, Action (PDCA) method popularized by
Toyota. In this study, the mixing process of Benzydamine HCl in the tablet
manufacturing process was changed from the extragranular phase to the
intragranular phase. The change in the mixing phase is proven to be able to
produce uniformity values for tablet content to meet the requirement, AV ?15%
and 85 - 115% assay value for its individual data. These results indicate that the
PDCA approach can be used to solve the issue of homogeneity of Benzydamine
HCl tablets, by changing the mixing phase of active ingredients in the tablet
manufacturing process.
|
---|